Pehlivan Umur Anil, Onan Hasan Bilen, Bayram Ertugrul, Keser Celalet, Paydas Semra
Radiology, Van Baskale State Hospital, Van, TUR.
Radiology, Çukurova University Faculty of Medicine, Adana, TUR.
Cureus. 2021 Nov 26;13(11):e19911. doi: 10.7759/cureus.19911. eCollection 2021 Nov.
Herein, we present a case of systemic aspergillosis with a fatal outcome in a case with diffuse large B cell lymphoma (DLBCL) treated by ibrutinib. Aspergillosis was suspected clinically and proven microbiologically. Radiological findings were compatible with aspergillosis. We aim to review radiological findings in a case with DLBCL treated with ibrutinib, which is an important tyrosine kinase inhibitor used in lymphoid neoplasias.
在此,我们报告一例接受依鲁替尼治疗的弥漫性大B细胞淋巴瘤(DLBCL)患者发生的系统性曲霉病,并导致致命结局。临床上怀疑为曲霉病,微生物学检查得以证实。影像学表现与曲霉病相符。我们旨在回顾一例接受依鲁替尼治疗的DLBCL患者的影像学表现,依鲁替尼是用于淋巴样肿瘤的一种重要的酪氨酸激酶抑制剂。